Skip to main content
Caplight Logo









Amplifi Vascular, Inc.

Amplifi Vascular, Inc.

Private
Chesterfield, MissouriHealthcare & Life Scienceshttps://amplifivascular.com/

Last Round

Seed Round

Mar 26, 2026

Total Funding Raised

$8.44M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amplifi Vascular, Inc. is a medical device company that develops the Amplifi Vein Dilation System, a technology designed to enlarge veins prior to arteriovenous fistula surgery for hemodialysis patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

vascular accesshemodialysisAVFarteriovenous fistulamedical devicefistula maturationvein dilationESRDend-stage renal diseasedialysis accessvascular surgeryclinical trialsnephrologymedtechIDE approval

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplifi Vascular, Inc. Comparables

Compare Amplifi Vascular, Inc. with similar companies based on industry and business-model similarity.

Amplifi Vascular, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Artio Medical
90%
VenoStent
89%
Advent Access Pte. Ltd.
85%

Amplifi Vascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 26, 2026
Series AOct 9, 2025
SeedAug 17, 2023

Key People

Founding team and executive leadership

Paul H. Müller

CTO GM

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 643% MoM, from 125 to 929.

  • Oct 9, 2025

    Received IDE approval from the U.S. Food and Drug Administration.

Amplifi Vascular, Inc. Filings

Explore SEC and related filing metadata, where available.

Amplifi Vascular, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amplifi Vascular, Inc.'s valuation, stock price, and market status.

Is Amplifi Vascular, Inc. a public or private company?

Amplifi Vascular, Inc. is a private company.

What is the current stock price of Amplifi Vascular, Inc.?

Amplifi Vascular, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Amplifi Vascular, Inc. worth (valuation)?

Valuation information for Amplifi Vascular, Inc. is not publicly available.

Can I buy Amplifi Vascular, Inc. stock?

Amplifi Vascular, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amplifi Vascular, Inc.'s last funding round?

Amplifi Vascular, Inc.'s most recent funding round was Seed Round on March 26, 2026.

Who are the main investors in Amplifi Vascular, Inc.?

Investor information for Amplifi Vascular, Inc. is not publicly disclosed.

Will Amplifi Vascular, Inc. IPO soon?

No public IPO plans have been announced for Amplifi Vascular, Inc..

How can I track Amplifi Vascular, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplifi Vascular, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChesterfield, Missouri
Employee Range10
Year Founded2023
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?